Physician profile
Adil Salam
NPI 1508850959
$3,010.33
in general payments reported to CMS, 2019-2025
25 companies · $22.34 in 2025
The $22.34 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,472 · 2020: $404 · 2021: $40.48 · 2022: $71.17 · 2025: $22.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $848.57 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $368.31 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.15 | 2019 | |
| Genentech USA, INC. | $209.27 | 2019-2021 | |
| Insmed, INC. | $196.41 | 2019-2020 | |
| Genzyme Corporation | $160.77 | 2019 | |
| Sunovion Pharmaceuticals INC. | $134.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $118.15 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $103.56 | 2019 | |
| Electromed, INC. | $78.83 | 2019 | |
| Mylan Specialty L.P. | $77.66 | 2019 | |
| Grifols USA, LLC | $70.22 | 2019 | |
| Shire North American Group INC | $69.39 | 2019 | |
| Lilly USA, LLC | $59.40 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $50.50 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.68 | 2019 | |
| Mallinckrodt Hospital Products INC. | $38.37 | 2020 | |
| Jazz Pharmaceuticals INC. | $29.03 | 2019 | |
| Philips North America LLC | $28.66 | 2019 | |
| Pulmonx Corporation | $22.34 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Harmony Biosciences LLC | $19.72 | 2020 | |
| United Therapeutics Corporation | $18.08 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.51 | 2019 | |
| Seqirus USA INC | $13.54 | 2019 | |
| Nabriva Therapeutics, Plc | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Salam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.